查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1478014

皮肤美容市场：依地区：全球产业分析、规模、占有率、成长、趋势、预测 2024-2031

Dermacosmetics Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球皮肤化妆品市场是更广泛的美容和个人护理行业中快速增长的细分市场，其特点是皮肤病学和化妆品的融合。该市场包括解决各种皮肤问题同时提供美容功效的产品，并且通常含有经过临床研究支持的活性成分。持久性市场研究深入研究皮肤美容市场动态，并提供关键成长驱动因素、课题、新兴趋势和竞争策略的见解。这项全面的分析为利害关係人驾驭 2024 年至 2031 年的市场奠定了坚实的基础。

预计2024年至2031年全球皮肤化妆品市场将以3.5%的复合年增长率成长，到2031年市场规模将达到247亿美元。

重要见解

  • 预计市场价值（2024年）：194亿美元
  • 预计市值（2031年）：247亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：3.5%

Derma 化妆品市场 - 报告范围：

皮肤美容产品通常将治疗性皮肤护理与美容吸引力结合起来，针对特定的皮肤问题，如痤疮、老化、色素沉着和阳光损伤。这些产品通常在医疗和临床环境中销售，并因其有效性和安全性而受到皮肤科医生的推荐。随着消费者对皮肤健康的兴趣日益浓厚，皮肤化妆品获得了巨大的关注，反映出人们转向兼具功能性和美容功效的产品。

社群媒体和名人代言的影响力日益增强，在市场扩张中发挥关键作用，关键意见领袖和影响者推动了消费者的兴趣。此外，随着消费者寻求外科手术和密集皮肤科手术的替代方案，对非侵入性皮肤护理解决方案的需求不断增长，正在推动皮肤化妆品的成长。

市场成长动力：

推动真皮化妆品市场成长的因素有很多。人们对皮肤护理和个人健康的兴趣日益浓厚，推动了消费者对有效、临床支援的产品的需求。电子商务平台和直接面向消费者的管道的扩张正在增加产品的获取并促进市场成长。

此外，世界人口老化和皮肤相关疾病的增加增加了对专业皮肤护理解决方案的需求。皮肤美容公司专注于产品创新，开发解决各种皮肤问题的配方，同时吸引不同的消费者偏好。随着消费者寻找有效且环保的产品，清洁和天然成分的成长趋势也推动了市场的成长。

市场限制：

儘管预计将出现强劲增长，但皮肤化妆品市场仍面临课题。高昂的研发成本以及对含有活性成分的产品的严格监管要求可能会限制中小企业的市场准入。此外，临床验证和皮肤病学批准的需要也是新产品推出的障碍。

消费者对产品声明的怀疑和行销缺乏透明度也阻碍了市场成长。市场上假冒和不受监管产品的氾滥正在侵蚀消费者的信任并影响合法皮肤化妆品品牌的销售。

市场机会：

皮肤美容市场有许多扩展和创新的机会。个人化皮肤护理的兴起是一个巨大的成长领域，它提供针对个人皮肤类型和问题的客製化产品。人工智慧驱动的皮肤分析和数位咨询等技术进步使公司能够提供客製化解决方案，提高消费者满意度。

皮肤美容公司与皮肤科医生和医疗专业人员之间的合作可以开发出更有效的产品并增强消费者的信心。此外，扩展到护肤意识不断增强的新兴市场代表着巨大的成长机会。

本报告解决的关键问题

  • 2024年至2031年真皮化妆品市场的预期复合年增长率是多少？
  • 皮肤美容市场的主要成长动力是什么？
  • 哪个地区在真皮化妆品市场中占有最大的市场占有率？
  • 谁是全球皮肤化妆品市场的主要参与者？
  • 皮肤美容市场的主要课题和商机是什么？

目录

第一章执行摘要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含/排除

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章 关键成功因素

  • 产品采用分析
  • 皮肤病流行病学
  • 最近的产品发布和批准
  • 监管场景
  • PESTLE分析
  • 波特分析
  • 供应链分析
  • 製造商采取的关键策略

第五章市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 市场动态

第 6 章 COVID-19 危机分析

  • COVID-19 与影响分析
    • 依治疗划分的收入
    • 依指标划分的收入
    • 依分销管道划分的收入
    • 国家收入
  • 2024年市场情景

第七章 皮肤美容市场需求（数量和规模）分析

  • 过去的市场（金额）分析，2019-2023
  • 当前和未来市场（价值）预测，2024-2031

第 8 章依治疗分类的皮肤美容市场分析

  • 简介/主要发现
  • 2019-2023年过去市场规模（金额）分析
  • 2024-2031年当前及未来市场规模（金额）分析与预测
    • 皮肤护理
    • 头髮护理
    • 抗衰老
    • 卫生
    • 防晒
    • 化妆品
    • 面部护理
    • 其他
  • 依处理方式进行市场吸引力分析

第九章皮肤化妆品市场分析（依适应症）

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2031
    • 皮肤干燥
    • 特应性皮肤湿疹
    • 色素沉着
    • 疤痕和痤疮
    • 银屑病
    • 深层皱纹
    • 其他
  • 依指标进行市场吸引力分析

第10章皮肤化妆品市场分析（依通路）

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2031
    • 医院药房
    • 零售药店
    • 电子商务商店
    • 大卖场和超级市场
    • 专科诊所
  • 依分销管道划分的市场吸引力分析

第十一章依地区划分的皮肤美容市场分析

  • 介绍
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2031
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 区域市场吸引力分析

第十二章北美皮肤美容市场分析

第十三章拉丁美洲皮肤美容市场分析

第14章欧洲皮肤化妆品市场分析

第十五章南亚皮肤美容市场分析

第十六章东亚皮肤美容市场分析

第十七章 大洋洲Derma化妆品市场分析

第十八章中东与非洲（MEA）皮肤美容市场分析

第十九章市场结构分析

  • 依公司层级进行市场分析
  • 主要参与者的市场占有率分析
  • 市场集中度
  • 市场存在分析

第 20 章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 衝突详情
    • Merck KGaA
    • Oxytical
    • L'Oreal Group
    • Cipla Inc.
    • Pierre Fabre group
    • Johnson &Johnson
    • NAOS
    • Puig
    • Swisskem Healthcare.
    • Kuora Dermo Cosmetics
    • Politech
    • CeraVe
    • GALDERMA LABORATORIES, LP
    • BEIERSDORF
    • Bausch Health Companies Inc.
    • Ultimate Skin Aesthetics GmbH
    • Procter & Gamble
    • Unilever
    • Coty
    • Colgate-Palmolive

第 21 章使用的假设和首字母缩略词

第22章研究方法论

简介目录
Product Code: PMRREP33162

The global dermacosmetics market is a rapidly growing sector within the broader beauty and personal care industry, characterized by the convergence of dermatology and cosmetics. This market encompasses products that address various skin concerns while providing aesthetic benefits, typically containing active ingredients backed by clinical research. Persistence Market Research delves into the dynamics of the dermacosmetics market, offering insights into key growth drivers, challenges, emerging trends, and competitive strategies. This comprehensive analysis provides a robust foundation for stakeholders to navigate the market from 2024 to 2031.

The global dermacosmetics market is expected to grow at a CAGR of 3.5% from 2024 to 2031, with a projected market size of USD 24.7 billion by 2031.

Key Insights:

  • Estimated Market Value (2024): USD 19.4 Billion
  • Projected Market Value (2031): USD 24.7 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 3.5%

Dermacosmetics Market - Report Scope:

Dermacosmetics products typically blend therapeutic skincare with aesthetic appeal, targeting specific skin issues such as acne, aging, pigmentation, and sun damage. These products are often sold in medical or clinical settings, with dermatologists recommending them for their efficacy and safety. With the growing consumer interest in skin health, dermacosmetics have gained significant traction, reflecting a shift toward products that offer both functional and cosmetic benefits.

The growing influence of social media and celebrity endorsements plays a significant role in market expansion, with key opinion leaders and influencers driving consumer interest. Furthermore, the rising demand for non-invasive skincare solutions propels the growth of dermacosmetics, with consumers seeking alternatives to surgical or intensive dermatological procedures.

Market Growth Drivers:

Several factors drive the growth of the dermacosmetics market. An increasing focus on skincare and personal well-being fuels consumer demand for effective, clinically-backed products. The expansion of e-commerce platforms and direct-to-consumer sales channels has improved product accessibility, contributing to market growth.

In addition, the aging global population and the rise in skin-related disorders increase the need for specialized skincare solutions. Dermacosmetics companies focus on product innovation, developing formulations that address a wide range of skin concerns while appealing to diverse consumer preferences. The growing trend towards clean and natural ingredients also drives market growth, as consumers seek products that are both effective and environmentally conscious.

Market Restraints:

Despite robust growth prospects, the dermacosmetics market faces challenges. The high cost of research and development, coupled with stringent regulatory requirements for products containing active ingredients, can limit market entry for smaller players. Additionally, the need for clinical validation and dermatological endorsements poses a barrier to new product launches.

Consumer skepticism regarding product claims and a lack of transparency in marketing can also hinder market growth. The growing prevalence of counterfeit and unregulated products in the market undermines consumer trust, impacting the sales of legitimate dermacosmetics brands.

Market Opportunities:

The dermacosmetics market offers numerous opportunities for expansion and innovation. The rise of personalized skincare, with products tailored to individual skin types and concerns, represents a significant growth area. Technological advancements, such as AI-based skin analysis and digital consultations, allow companies to offer customized solutions, enhancing consumer satisfaction.

Collaborations between dermacosmetics companies and dermatologists or medical professionals can lead to the development of more effective products and increase consumer trust. Moreover, expanding into emerging markets, where skincare awareness is rising, presents a significant growth opportunity.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Dermacosmetics Market from 2024 to 2031?
  • What are the Key Growth Drivers for the Dermacosmetics Market?
  • Which Region Holds the Largest Market Share in the Dermacosmetics Market?
  • Who are the Key Players in the Global Dermacosmetics Market?
  • What Are the Main Challenges and Opportunities in the Dermacosmetics Market?

Competitive Landscape and Business Strategies:

The competitive landscape of the dermacosmetics market features both established companies and emerging players. Leading firms like L'Oreal, Estee Lauder, and Johnson & Johnson focus on innovation and strategic acquisitions to strengthen their market position. Partnerships with dermatologists and healthcare professionals are common strategies to boost credibility and product endorsement.

Companies also invest in extensive marketing campaigns and collaborations with social media influencers to reach a wider audience. Sustainability and ethical sourcing are becoming increasingly important, with companies adopting eco-friendly practices and emphasizing clean ingredient formulations to meet consumer expectations.

Key Companies Profiled:

  • L'Oreal S.A.
  • Estee Lauder Companies Inc.
  • Johnson & Johnson
  • Procter & Gamble Co.
  • Unilever
  • Shiseido Company, Limited
  • Beiersdorf AG
  • Amorepacific Corporation
  • Pierre Fabre Group
  • Galderma Laboratories, L.P.

Dermacosmetics Market Segmentation:

By Treatment:

  • Skin Care
  • Hair Care
  • Anti-aging
  • Hygiene
  • Sun Care
  • Cosmetics
  • Facial care
  • Others

By Indication:

  • Dry Skin
  • Atopic Skin Eczema
  • Hyperpigmentation
  • Scar & Acne
  • Psoriasis
  • Deep Wrinkles
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce stores
  • Hypermarkets & Supermarkets
  • Speciality Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Skin Diseases Epidemiology
  • 4.3. Recent Product Launches and Approvals
  • 4.4. Regulatory Scenario
  • 4.5. PESTLE Analysis
  • 4.6. Porters Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Key Strategies Adopted By Manufacturers

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cosmetics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Pharmaceutical and Biotechnology R&D Expenditure
    • 5.2.2. Custom Products Offerings for Specific Needs
    • 5.2.3. Increasing Preventives of Specific Skin Conditions
    • 5.2.4. Availability of a Range of Skincare Products
    • 5.2.5. Increasing Commercialization of Novel Products
    • 5.2.6. Key Regulation Policies
    • 5.2.7. Strategic Mergers and Acquisitions Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Treatment
    • 6.1.2. Revenue By Indication
    • 6.1.3. Revenue By Distribution Channel
    • 6.1.4. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Dermacosmetics Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Treatment

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2024-2031
    • 8.3.1. Skin Care
    • 8.3.2. Hair Care
    • 8.3.3. Anti-Aging
    • 8.3.4. Hygiene
    • 8.3.5. Sun Care
    • 8.3.6. Cosmetics
    • 8.3.7. Facial Care
    • 8.3.8. Others
  • 8.4. Market Attractiveness Analysis By Treatment

9. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2031
    • 9.3.1. Dry Skin
    • 9.3.2. Atopic Skin Eczema
    • 9.3.3. Hyperpigmentation
    • 9.3.4. Scar & Acne
    • 9.3.5. Psoriasis
    • 9.3.6. Deep Wrinkles
    • 9.3.7. Others
  • 9.4. Market Attractiveness Analysis By Indication

10. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. E-commerce stores
    • 10.3.4. Hypermarkets & supermarkets
    • 10.3.5. Speciality Clinics
  • 10.4. Market Attractiveness Analysis By Distribution Channel

11. Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Treatment
    • 12.3.3. By Indication
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Treatment
    • 12.4.3. By Indication
    • 12.4.4. By Distribution Channel
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Market Trends
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Dermacosmetics Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Treatment
        • 12.8.1.2.2. By Indication
        • 12.8.1.2.3. By Distribution Channel
    • 12.8.2. Canada Dermacosmetics Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Treatment
        • 12.8.2.2.2. By Indication
        • 12.8.2.2.3. By Distribution Channel

13. Latin America Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Treatment
    • 13.3.3. By Indication
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Treatment
    • 13.4.3. By Indication
    • 13.4.4. By Distribution Channel
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Market Trends
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Brazil Dermacosmetics Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Treatment
        • 13.8.1.2.2. By Indication
        • 13.8.1.2.3. By Distribution Channel
    • 13.8.2. Mexico Dermacosmetics Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Treatment
        • 13.8.2.2.2. By Indication
        • 13.8.2.2.3. By Distribution Channel
    • 13.8.3. Argentina Dermacosmetics Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Treatment
        • 13.8.3.2.2. By Indication
        • 13.8.3.2.3. By Distribution Channel

14. Europe Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Nordic Countries
      • 14.3.1.8. Russia
      • 14.3.1.9. Rest of Europe
    • 14.3.2. By Treatment
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Treatment
    • 14.4.3. By Indication
    • 14.4.4. By Distribution Channel
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Market Trends
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Dermacosmetics Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Treatment
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. France Dermacosmetics Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Treatment
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. Italy Dermacosmetics Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Treatment
        • 14.8.3.2.2. By Indication
        • 14.8.3.2.3. By Distribution Channel
    • 14.8.4. Spain Dermacosmetics Market
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Treatment
        • 14.8.4.2.2. By Indication
        • 14.8.4.2.3. By Distribution Channel
    • 14.8.5. U.K. Dermacosmetics Market
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Treatment
        • 14.8.5.2.2. By Indication
        • 14.8.5.2.3. By Distribution Channel
    • 14.8.6. Benelux Union Dermacosmetics Market
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Treatment
        • 14.8.6.2.2. By Indication
        • 14.8.6.2.3. By Distribution Channel
    • 14.8.7. Nordic Countries Dermacosmetics Market
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Treatment
        • 14.8.7.2.2. By Indication
        • 14.8.7.2.3. By Distribution Channel
    • 14.8.8. Russia Dermacosmetics Market
      • 14.8.8.1. Introduction
      • 14.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.8.2.1. By Treatment
        • 14.8.8.2.2. By Indication
        • 14.8.8.2.3. By Distribution Channel

15. South Asia Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Treatment
    • 15.3.3. By Indication
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Treatment
    • 15.4.3. By Indication
    • 15.4.4. By Distribution Channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Market Trends
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Dermacosmetics Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Treatment
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Indonesia Dermacosmetics Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Treatment
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. Malaysia Dermacosmetics Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Treatment
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Distribution Channel
    • 15.8.4. Thailand Dermacosmetics Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Treatment
        • 15.8.4.2.2. By Indication
        • 15.8.4.2.3. By Distribution Channel

16. East Asia Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Treatment
    • 16.3.3. By Indication
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Treatment
    • 16.4.3. By Indication
    • 16.4.4. By Distribution Channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Market Trends
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Dermacosmetics Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Treatment
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Japan Dermacosmetics Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Treatment
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. South Korea Dermacosmetics Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Treatment
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Distribution Channel

17. Oceania Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Treatment
    • 17.3.3. By Indication
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Treatment
    • 17.4.3. By Indication
    • 17.4.4. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Market Trends
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Dermacosmetics Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Treatment
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. New Zealand Dermacosmetics Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Treatment
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Dermacosmetics Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Treatment
    • 18.3.3. By Indication
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Treatment
    • 18.4.3. By Indication
    • 18.4.4. By Distribution Channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Dermacosmetics Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Treatment
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Turkey Dermacosmetics Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Treatment
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. North Africa Dermacosmetics Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Treatment
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. South Africa Dermacosmetics Market
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Treatment
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis
    • 19.4.1. Regional Footprint Analysis
    • 19.4.2. Treatment Footprint Analysis
    • 19.4.3. Channel Footprint Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Merck KGaA
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Key Financials
      • 20.3.1.4. SWOT Analysis
      • 20.3.1.5. Sales Footprint
      • 20.3.1.6. Strategy Overview
      • 20.3.1.7. Key Developments
        • 20.3.1.7.1. Marketing Strategies
        • 20.3.1.7.2. Product Strategies
        • 20.3.1.7.3. Channel Strategies
    • 20.3.2. Oxytical
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Key Financials
      • 20.3.2.4. SWOT Analysis
      • 20.3.2.5. Sales Footprint
      • 20.3.2.6. Strategy Overview
      • 20.3.2.7. Key Developments
        • 20.3.2.7.1. Marketing Strategies
        • 20.3.2.7.2. Product Strategies
        • 20.3.2.7.3. Channel Strategies
    • 20.3.3. L'Oreal Group
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Key Financials
      • 20.3.3.4. SWOT Analysis
      • 20.3.3.5. Sales Footprint
      • 20.3.3.6. Strategy Overview
      • 20.3.3.7. Key Developments
        • 20.3.3.7.1. Marketing Strategies
        • 20.3.3.7.2. Product Strategies
        • 20.3.3.7.3. Channel Strategies
    • 20.3.4. Cipla Inc.
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Key Financials
      • 20.3.4.4. SWOT Analysis
      • 20.3.4.5. Sales Footprint
      • 20.3.4.6. Strategy Overview
      • 20.3.4.7. Key Developments
        • 20.3.4.7.1. Marketing Strategies
        • 20.3.4.7.2. Product Strategies
        • 20.3.4.7.3. Channel Strategies
    • 20.3.5. Pierre Fabre group
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Key Financials
      • 20.3.5.4. SWOT Analysis
      • 20.3.5.5. Sales Footprint
      • 20.3.5.6. Strategy Overview
      • 20.3.5.7. Key Developments
        • 20.3.5.7.1. Marketing Strategies
        • 20.3.5.7.2. Product Strategies
        • 20.3.5.7.3. Channel Strategies
    • 20.3.6. Johnson & Johnson
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Key Financials
      • 20.3.6.4. SWOT Analysis
      • 20.3.6.5. Sales Footprint
      • 20.3.6.6. Strategy Overview
      • 20.3.6.7. Key Developments
        • 20.3.6.7.1. Marketing Strategies
        • 20.3.6.7.2. Product Strategies
        • 20.3.6.7.3. Channel Strategies
    • 20.3.7. NAOS
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Key Financials
      • 20.3.7.4. SWOT Analysis
      • 20.3.7.5. Sales Footprint
      • 20.3.7.6. Strategy Overview
      • 20.3.7.7. Key Developments
        • 20.3.7.7.1. Marketing Strategies
        • 20.3.7.7.2. Product Strategies
        • 20.3.7.7.3. Channel Strategies
    • 20.3.8. Puig
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Key Financials
      • 20.3.8.4. SWOT Analysis
      • 20.3.8.5. Sales Footprint
      • 20.3.8.6. Strategy Overview
      • 20.3.8.7. Key Developments
        • 20.3.8.7.1. Marketing Strategies
        • 20.3.8.7.2. Product Strategies
        • 20.3.8.7.3. Channel Strategies
    • 20.3.9. Swisskem Healthcare.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Key Financials
      • 20.3.9.4. SWOT Analysis
      • 20.3.9.5. Sales Footprint
      • 20.3.9.6. Strategy Overview
      • 20.3.9.7. Key Developments
        • 20.3.9.7.1. Marketing Strategies
        • 20.3.9.7.2. Product Strategies
        • 20.3.9.7.3. Channel Strategies
    • 20.3.10. Kuora Dermo Cosmetics
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Key Financials
      • 20.3.10.4. SWOT Analysis
      • 20.3.10.5. Sales Footprint
      • 20.3.10.6. Strategy Overview
      • 20.3.10.7. Key Developments
        • 20.3.10.7.1. Marketing Strategies
        • 20.3.10.7.2. Product Strategies
        • 20.3.10.7.3. Channel Strategies
    • 20.3.11. Politech
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Key Financials
      • 20.3.11.4. SWOT Analysis
      • 20.3.11.5. Sales Footprint
      • 20.3.11.6. Strategy Overview
      • 20.3.11.7. Key Developments
        • 20.3.11.7.1. Marketing Strategies
        • 20.3.11.7.2. Product Strategies
        • 20.3.11.7.3. Channel Strategies
    • 20.3.12. CeraVe
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Key Financials
      • 20.3.12.4. SWOT Analysis
      • 20.3.12.5. Sales Footprint
      • 20.3.12.6. Strategy Overview
      • 20.3.12.7. Key Developments
        • 20.3.12.7.1. Marketing Strategies
        • 20.3.12.7.2. Product Strategies
        • 20.3.12.7.3. Channel Strategies
    • 20.3.13. GALDERMA LABORATORIES, L.P.
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Key Financials
      • 20.3.13.4. SWOT Analysis
      • 20.3.13.5. Sales Footprint
      • 20.3.13.6. Strategy Overview
      • 20.3.13.7. Key Developments
        • 20.3.13.7.1. Marketing Strategies
        • 20.3.13.7.2. Product Strategies
        • 20.3.13.7.3. Channel Strategies
    • 20.3.14. BEIERSDORF
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Key Financials
      • 20.3.14.4. SWOT Analysis
      • 20.3.14.5. Sales Footprint
      • 20.3.14.6. Strategy Overview
      • 20.3.14.7. Key Developments
        • 20.3.14.7.1. Marketing Strategies
        • 20.3.14.7.2. Product Strategies
        • 20.3.14.7.3. Channel Strategies
    • 20.3.15. Bausch Health Companies Inc.
      • 20.3.15.1. Overview
      • 20.3.15.2. Product Portfolio
      • 20.3.15.3. Key Financials
      • 20.3.15.4. SWOT Analysis
      • 20.3.15.5. Sales Footprint
      • 20.3.15.6. Strategy Overview
      • 20.3.15.7. Key Developments
        • 20.3.15.7.1. Marketing Strategies
        • 20.3.15.7.2. Product Strategies
        • 20.3.15.7.3. Channel Strategies
    • 20.3.16. Ultimate Skin Aesthetics GmbH
      • 20.3.16.1. Overview
      • 20.3.16.2. Product Portfolio
      • 20.3.16.3. Key Financials
      • 20.3.16.4. SWOT Analysis
      • 20.3.16.5. Sales Footprint
      • 20.3.16.6. Strategy Overview
      • 20.3.16.7. Key Developments
        • 20.3.16.7.1. Marketing Strategies
        • 20.3.16.7.2. Product Strategies
        • 20.3.16.7.3. Channel Strategies
    • 20.3.17. Procter & Gamble
      • 20.3.17.1. Overview
      • 20.3.17.2. Product Portfolio
      • 20.3.17.3. Key Financials
      • 20.3.17.4. SWOT Analysis
      • 20.3.17.5. Sales Footprint
      • 20.3.17.6. Strategy Overview
      • 20.3.17.7. Key Developments
        • 20.3.17.7.1. Marketing Strategies
        • 20.3.17.7.2. Product Strategies
        • 20.3.17.7.3. Channel Strategies
    • 20.3.18. Unilever
      • 20.3.18.1. Overview
      • 20.3.18.2. Product Portfolio
      • 20.3.18.3. Key Financials
      • 20.3.18.4. SWOT Analysis
      • 20.3.18.5. Sales Footprint
      • 20.3.18.6. Strategy Overview
      • 20.3.18.7. Key Developments
        • 20.3.18.7.1. Marketing Strategies
        • 20.3.18.7.2. Product Strategies
        • 20.3.18.7.3. Channel Strategies
    • 20.3.19. Coty
      • 20.3.19.1. Overview
      • 20.3.19.2. Product Portfolio
      • 20.3.19.3. Key Financials
      • 20.3.19.4. SWOT Analysis
      • 20.3.19.5. Sales Footprint
      • 20.3.19.6. Strategy Overview
      • 20.3.19.7. Key Developments
        • 20.3.19.7.1. Marketing Strategies
        • 20.3.19.7.2. Product Strategies
        • 20.3.19.7.3. Channel Strategies
    • 20.3.20. Colgate-Palmolive
      • 20.3.20.1. Overview
      • 20.3.20.2. Product Portfolio
      • 20.3.20.3. Key Financials
      • 20.3.20.4. SWOT Analysis
      • 20.3.20.5. Sales Footprint
      • 20.3.20.6. Strategy Overview
      • 20.3.20.7. Key Developments
        • 20.3.20.7.1. Marketing Strategies
        • 20.3.20.7.2. Product Strategies
        • 20.3.20.7.3. Channel Strategies

21. Assumptions and Acronyms Used

22. Research Methodology